Company Overview of Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. engages in the discovery and development of a pipeline of cancer immunotherapy treatments for a range of cancers. Its immunotherapies are designed to harness the patient's immune system to seek out and attack cancerous cells and tumors. Jounce Therapeutics, Inc. has a strategic collaboration with Celgene Corp. The company was incorporated in 2012 and is based in Cambridge, Massachusetts.
1030 Massachusetts Avenue
Cambridge, MA 02138
Founded in 2012
Key Executives for Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
July 19, 2016
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Jounce Therapeutics, Inc., please visit www.jouncetx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.